Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

Saved in:

Bibliographic Details
Main Authors:	Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-02-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-025-57244-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy
by: Jiefei Han, et al.
Published: (2024-02-01)

Shared neoantigens for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-06-01)

Neoantigen prioritization based on antigen processing and presentation
by: Serina Tokita, et al.
Published: (2024-11-01)

Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)

Potential shared neoantigens from pan-cancer transcript isoforms
by: Jirapat Techachakrit, et al.
Published: (2025-05-01)

Neoantigen vaccines: advancing personalized cancer immunotherapy
by: Alaa A. A. Aljabali, et al.
Published: (2025-04-01)

Advances and challenges in neoantigen prediction for cancer immunotherapy
by: Yi Zhang, et al.
Published: (2025-06-01)

Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy
by: Yuwei Li, et al.
Published: (2025-05-01)

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
by: Belen Aparicio, et al.
Published: (2024-12-01)

Computation strategies and clinical applications in neoantigen discovery towards precision cancer immunotherapy
by: Zhenchang Wang, et al.
Published: (2025-07-01)

Blood group antigens visualisation on leukocytes
by: Grigorovich Kravchun Pavlo, et al.
Published: (2024-01-01)

Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report
by: Wei Zhang, et al.
Published: (2020-05-01)

Advances in neoantigen-based immunotherapy for head and neck squamous cell carcinoma: a comprehensive review
by: Manzhu Jiang, et al.
Published: (2025-05-01)

Targeting Antigen‐Presenting Cells to Enhance the Tumor‐Spleen Immunity Cycle through Liposome‐Neoantigen Vaccine
by: Yu Xu, et al.
Published: (2025-05-01)

Imputing amino acid polymorphisms in human leukocyte antigens.
by: Xiaoming Jia, et al.
Published: (2013-01-01)

Using high-resolution human leukocyte antigen typing of 11,423 randomized unrelated individuals to determine allelic varieties, deduce probable human leukocyte antigen haplotypes, and observe linkage disequilibria between human leukocyte antigen-B and-C and human leukocyte antigen-DRB1 and-DQB1 alleles in the Taiwanese Chinese population
by: Kuo-Liang Yang, et al.
Published: (2017-01-01)

Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy
by: Deepa Kolaseri Krishnadas, et al.
Published: (2017-07-01)

Deduced probable human leukocyte antigen haplotypes associated with human leukocyte antigen DRB1*04:36 identified by case analysis of Taiwanese individuals
by: Kuo-Liang Yang, et al.
Published: (2017-01-01)

Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
by: Moawiah M Naffaa, et al.
Published: (2025-04-01)

A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice
by: Qing Li, et al.
Published: (2024-11-01)

High-throughput, pan-leukocyte biomarkers for the detection of inflammation in human breastmilk and stool
by: M. J. Dunnet, et al.
Published: (2025-02-01)

Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy
by: Shinji Morisaki, et al.
Published: (2025-05-01)

Polymerised superparamagnetic antigen presenting cell lymphocyte capture for enriching tumour reactive T-cells and neoantigen identification
by: Chung-Yao Hsu, et al.
Published: (2025-06-01)

Human leukocyte antigen associations with acute leukemia: An indian perspective
by: Hina Solanki, et al.
Published: (2020-01-01)

Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
by: Lineu Cesar Werneck, et al.

The Impact of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen-E, Human Leukocyte Antigen-G Polymorphisms on Innate Immunity and COVID-19 Severity
by: Cigdem Kekik, et al.
Published: (2025-01-01)

Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy
by: Yufeng Guo, et al.
Published: (2025-03-01)

Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
by: Stefani Spranger, et al.
Published: (2024-11-01)

Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer
by: Joanna Fréderique de Graaf, et al.
Published: (2024-09-01)

Human leukocyte antigen - HLA B*27: Unraveling the link to pathogenesis
by: Sakir Ahmed, et al.
Published: (2020-01-01)

Two probable human leukocyte antigen haplotypes in association with human leukocyte antigen HLA-DRB1*13:50:01 identified in 41 randomized unrelated Taiwanese individuals
by: Nondumiso Ayanda Mazibuko, et al.
Published: (2021-01-01)

Reversing the “cold” tumor microenvironment: the role of neoantigen vaccines in prostate cancer
by: Jiani Wang, et al.
Published: (2025-07-01)

Unveiling the immunological landscape: comprehensive characterization of neoantigen-reactive immune cells in neoantigen cancer vaccines
by: Weijiang Liu, et al.
Published: (2025-03-01)

Human leukocyte antigen-A*33:03-B*58:01-DRB1*15:140, a deduced probable human leukocyte antigen haplotype in association with a human leukocyte antigen low-incidence allele DRB1*15:140 in Taiwanese individuals: A case analysis
by: Kuo-Liang Yang, et al.
Published: (2019-01-01)

Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections
by: Sadeep Medhasi, et al.
Published: (2022-01-01)

Mapping the Human Leukocyte Antigen Diversity among Croatian Regions: Implication in Transplantation
by: Zorana Grubic, et al.
Published: (2021-01-01)

Allele-Independent Turnover of Human Leukocyte Antigen (HLA) Class Ia Molecules.
by: Claudia Prevosto, et al.
Published: (2016-01-01)

Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy
by: Rui Han, et al.
Published: (2025-05-01)

Human leukocyte antigen-A*24:02-B*40:247-C*03:04-DRB1*16:02, a deduced probable human leukocyte antigen haplotype associated with a low-incidence human leukocyte antigen allele B*40:247 in Taiwanese individuals: A case analysis
by: Kuo-Liang Yang, et al.
Published: (2018-01-01)

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H
by: Volker Lennerz, et al.
Published: (2025-03-01)